Yes, gene silencing is often a reversible process. Epigenetic therapies, such as DNA methyltransferase inhibitors and histone deacetylase inhibitors, are being developed to reactivate silenced tumor suppressor genes. These therapies aim to restore normal gene function and inhibit cancer progression.
